On June 3, 2019, Marilyn G. Geller, CEO of the Celiac Disease Foundation, submitted Outside Witness Testimony to the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.

      Outside Witness Testimony – Fiscal Year 2020 Appropriations Prepared By Marilyn G. Geller, CEO, Celiac Disease Foundation Prepared for the Subcommittee on Labor, Health and Human Services, Education and Related Agencies Committee on Appropriations United States Senate June 3, 2019 ______________________________ Chairman Blunt, Ranking Member Murray, and distinguished Members of the Subcommittee,…

On April 9, 2019, Marilyn G. Geller, CEO of the Celiac Disease Foundation, testified before the House Appropriations Subcommittee overseeing the funding for the Department of Health and Human Services, including the National Institutes of Health (NIH).

We have great news to share from Washington, D.C. Today, the U.S. House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies released report language under the National Institute of Allergy and Infectious Diseases.

If you have celiac disease and currently have kidney stones, or have had kidney stones in the past, you may be eligible for a clinical research study!

Cupcakes with razorblades. Pizza with scorpions. Pasta Salad with thumbtacks. In the eyes of someone suffering from celiac disease, this is what food with gluten looks like because it’s also what it feels like.

There is significant overlap between NCGS and IBS. Gluten may not be the only culprit; other wheat compounds also play roles that might be the key to the difference in how NCGS and IBS are affected by eating wheat.

The Celiac Disease Foundation was proud to be a sponsor of the MedAboutData Hackathon in Haifa, Israel. During the hackathon, the ‘CeliACT’ team presented an innovative product that can assist in early detection of celiac disease.

Representatives Tim Ryan (D-OH) and Tom Cole (R-OK) introduced H.R. 2074, the Gluten in Medicine Disclosure Act of 2019. The bill intends to make it easier to identify gluten in prescription medications.

If you have celiac disease and currently have kidney stones, or have had kidney stones in the past, you may be eligible for a clinical research study!